Funder
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | National Institutes of Health
Breast Cancer Research Foundation
Cancer Prevention and Research Institute of Texas
Publisher
Springer Science and Business Media LLC
Reference97 articles.
1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424.
2. National Cancer Institute Surveillance Epidemiology and End Results Program. Cancer stat facts: female breast cancer subtypes: NIH; 2017. https://seer.cancer.gov/statfacts/html/breastsubtypes.%20html#:~:text=The%20breast%cancer%subtype%HR,based%on%202013%E2%80%932017%20cases.
3. Network NCC Breast Cancer (Version 6.2020). 2020. Available from: https://www.nccn.org/professionals/physician_gls/pdf/breast.pdf.
4. Early Breast Cancer Trialists’ Collaborative G. Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials. Lancet. 2015;386:1341–52.
5. Schiavon G, Hrebien S, Garcia-Murillas I, Cutts RJ, Pearson A, Tarazona N, et al. Analysis of ESR1 mutation in circulating tumor DNA demonstrates evolution during therapy for metastatic breast cancer. Sci Transl Med. 2015;7:313ra182.
Cited by
68 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献